Searched for
PHARMACEUTICAL STOCKS
Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...- Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 targetJefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is ...
- Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswingOn August 20, five Nifty500 stocks that gained over 4% were identified using the RSI Trending Up scan, based on data from StockEdge.com. An...
- Capitalmind Flexi Cap Fund exits Vedanta and 10 others; adds 9 stocksDeepak Shenoy-backed Capitalmind Flexi Cap Fund exited 11 stocks, including Vedanta and Vedanta Oil and Gas, and added nine stocks, includi...
- Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...
- Credent Connect shares make strong market debut, list at 90% premium over IPO price on NSE SME platformCredent Connect N Care shares made a blockbuster debut on the NSE SME platform, listing at a 90% premium over the IPO price. The Rs 93.90-c...
- Lenskart Solutions among 4 stocks to hit 52-week highs & surge up to 25% in a monthFour BSE 200 stocks—GlaxoSmithKline Pharmaceuticals, Lenskart Solutions, Bosch and Samvardhana Motherson International—hit fresh 52-week hi...
- Samir Arora-backed Helios Mid Cap Fund hikes stake in Swiggy and 20 others, trims exposure in 2 stocksIn July, Helios Mid Cap Fund boosted its investments by increasing its stake in Swiggy among twenty other stocks. Notably, the fund expande...
- Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a monthFive BSE Midcap stocks—KEI Industries, GSK Pharmaceuticals, Lenskart Solutions, Radico Khaitan and Ajanta Pharma—hit fresh 52-week highs de...
- NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...
- BSE, RIL, Paytm among stocks bought and sold by HDFC Mutual Fund in JulyJuly was a busy month for HDFC Mutual Fund, which ramped up its investments by increasing its stakes in about 422 stocks. Simultaneously, t...
- Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepinessLupin received USFDA approval for generic Pitolisant Tablets, strengthening its US portfolio and specialty generics presence. Shares remain...
- Two Trades for Today: A capital market player for a 6.45% rise, a mid-cap pharma stock for an almost 6% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Global Markets: Hotter Europe isn't cooling investor fervor for stocksThe heatwaves pummelling Europe this summer will have costly impacts on industries ranging from agriculture to tourism -- but that hasn't s...
- Quant Mid Cap Fund exits Anthem Biosciences and Lenskart Solutions, adds Cochin Shipyard and 4 others in JulyQuant Mid Cap Fund exited Anthem Biosciences and Lenskart Solutions in July, while adding five new stocks including Cochin Shipyard, UPL an...
- Global Market: Japan’s Nikkei extends weekly gains as softer US inflation boosts risk appetiteJapan’s Nikkei 225 rose nearly 1% on Friday and was on track for a strong weekly gain, supported by softer-than-expected US producer prices...
- MFs cut PSU bank exposure, raise bets on IT, auto & pharma in JulyIn July, fund managers recalibrated their blue-chip stock portfolios, focusing on select sectors like IT, automotive, and pharmaceuticals f...
- Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 croreZydus Lifesciences reported a significant year-on-year decline of thirty-six percent in net profit for the first quarter, despite a robust ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
Load More
